AstraZeneca Can’t Block Generic Nexium During Appeal

Law360, New York (September 13, 2013, 6:28 PM ET) -- A New Jersey federal judge on Friday rejected AstraZeneca AB's bid to delay a generic version of its acid reflux drug Nexium manufactured by South Korea's Hanmi Pharmaceutical Co. Ltd. while AstraZeneca awaits the outcome of an appeal challenging a decision that hindered its patent infringement claims.

U.S. District Judge Joel Pisano denied AstraZeneca's request for a temporary injunction blocking Hanmi's recently released Esomezol drug. AstraZeneca was seeking a U.S. sales ban on Esomezol pending the outcome of its appeal challenging a claim construction ruling that...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required